184 related articles for article (PubMed ID: 2070081)
21. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow.
van Rhee F; Marks DI; Lin F; Szydlo RM; Hochhaus A; Treleaven J; Delord C; Cross NC; Goldman JM
Leukemia; 1995 Feb; 9(2):329-35. PubMed ID: 7869772
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia.
Stockschläder M; Hegewisch-Becker S; Krüger W; tom Dieck A; Mross K; Hoffknecht M; Berger C; Kohlschütter B; Martin H; Peters S
Bone Marrow Transplant; 1995 Nov; 16(5):663-7. PubMed ID: 8547863
[TBL] [Abstract][Full Text] [Related]
23. Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation.
Lee M; Khouri I; Champlin R; Kantarjian H; Talpaz M; Trujillo J; Freireich E; Deisseroth A; Stass S
Br J Haematol; 1992 Dec; 82(4):708-14. PubMed ID: 1482658
[TBL] [Abstract][Full Text] [Related]
24. Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia.
Melo JV; Gordon DE; Tuszynski A; Dhut S; Young BD; Goldman JM
Blood; 1993 May; 81(10):2488-91. PubMed ID: 8490164
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
Serrano J; Roman J; Sanchez J; Jimenez A; Castillejo JA; Herrera C; Gonzalez MG; Reina L; Rodriguez MC; Alvarez MA; Maldonado J; Torres A
Blood; 2000 Apr; 95(8):2659-65. PubMed ID: 10753848
[TBL] [Abstract][Full Text] [Related]
26. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Hidaka M; Inokuchi K; Uoshima N; Takahashi N; Yoshida N; Ota S; Nakamae H; Iwasaki H; Watanabe K; Kosaka Y; Komatsu N; Meguro K; Najima Y; Eto T; Kondo T; Kimura S; Yoshida C; Ishikawa Y; Sawa M; Hata T; Horibe K; Iida H; Shimomura T; Dobashi N; Sugiura I; Makiyama J; Miyagawa N; Sato A; Ito R; Matsumura I; Kanakura Y; Naoe T
Jpn J Clin Oncol; 2024 Feb; 54(2):153-159. PubMed ID: 37986553
[TBL] [Abstract][Full Text] [Related]
28. Detection of minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia: rationale for bone marrow transplantation from the polymerase chain reaction point of view.
Miyamura K; Takeo T; Kataoka T; Tahara T; Tanimoto M; Saito H
Leuk Lymphoma; 1993 Oct; 11(3-4):181-9. PubMed ID: 8260893
[TBL] [Abstract][Full Text] [Related]
29. Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction.
Radich JP; Kopecky KJ; Boldt DH; Head D; Slovak ML; Babu R; Kirk J; Lee A; Kessler P; Appelbaum F
Leukemia; 1994 Oct; 8(10):1688-95. PubMed ID: 7934164
[TBL] [Abstract][Full Text] [Related]
30. Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Lange W; Herkert R; Finke J; Ragoczy U; Siegert W; Mertelsmann R; Dölken G
Ann Hematol; 1991 Oct; 63(4):189-94. PubMed ID: 1932296
[TBL] [Abstract][Full Text] [Related]
31. bcr/abl mRNA detection following bone marrow transplantation for chronic myelogenous leukemia.
Ely P; Miller WJ
Transplantation; 1991 Dec; 52(6):1023-8. PubMed ID: 1750065
[TBL] [Abstract][Full Text] [Related]
32. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW
Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354
[TBL] [Abstract][Full Text] [Related]
33. Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remission.
Diekmann L; Beelen DW; Quabeck K; Becher R; Schulte Holthausen H; Bützler R; Schaefer UW; Opalka B
Acta Haematol; 1994; 92(4):169-75. PubMed ID: 7701913
[TBL] [Abstract][Full Text] [Related]
34. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
35. Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. BFM Relapse Study Group.
Beyermann B; Agthe AG; Adams HP; Seeger K; Linderkamp C; Goetze G; Ludwig WD; Henze G
Blood; 1996 Feb; 87(4):1532-8. PubMed ID: 8608244
[TBL] [Abstract][Full Text] [Related]
36. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Matsue K; Tabayashi T; Yamada K; Takeuchi M
Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
[TBL] [Abstract][Full Text] [Related]
37. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants.
Guerrasio A; Martinelli G; Saglio G; Rosso C; Zaccaria A; Rosti G; Testoni N; Ambrosetti A; Izzi T; Sessarego M
Leukemia; 1992 Jun; 6(6):507-12. PubMed ID: 1602789
[TBL] [Abstract][Full Text] [Related]
38. bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase.
Frassoni F; Martinelli G; Saglio G; Sessarego M; Podestà M; Piaggio G; Farabegoli P; Zaccaria A; Testoni N; Remiddi C
Bone Marrow Transplant; 1995 Oct; 16(4):595-601. PubMed ID: 8528178
[TBL] [Abstract][Full Text] [Related]
39. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
40. Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Hooberman AL; Carrino JJ; Leibowitz D; Rowley JD; Le Beau MM; Arlin ZA; Westbrook CA
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4259-63. PubMed ID: 2498881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]